Skip to main content

Outcomes 3


Used for 20 minutes, once or twice a day, the Fisher Wallace Stimulator® is cleared by the FDA for the treatment of depression, anxiety and insomnia. In clinical trials, the majority of patients experienced durable reduction or remission of symptoms within the first two weeks of daily use. Patients may return their device for a refund if it does not reduce their symptoms. The device is comfortable and easy to use, and works by stimulating the brain to produce serotonin and lower cortisol, without the side effects of medication. The device is safe to use in conjunction with antidepressant and anxiety medication, or may be used as a standalone therapy. No negative effects resulting from long term use of the device have been reported since the device first came to market in 1990.



Invented by electrical engineers in partnership with physicians and research scientists, the Fisher Wallace Stimulator® received FDA-Clearance for the treatment of depression, anxiety, insomnia in 1990 under the original brand name Liss Cranial Stimulator®. In 2006, entrepreneur Charles Fisher and addiction researcher Martin Wallace, PhD, purchased the patents to the device and Kelly Roman later joined as co-founder. By 2010, several hundred psychiatrists were prescribing the device and finding it to be effective with thousands of treatment-resistant patients. Additional clinical research was launched at Mount Sinai Beth Israel Hospital and Phoenix House, and a landmark bipolar depression study was published in 2015. In 2017, Medicaid in Maine (MaineCare) approved the Fisher Wallace Stimulator® for full coverage. Today, more than 9000 providers - including psychiatrists, primary care providers, and telemedicine providers - recommend the Fisher Wallace Stimulator® to their patients.

Back to top